Impact of tocilizumab on clinical outcomes in severe COVID-19 patients and risk of secondary infection: A case-control study

ERTÜRK ŞENGEL B., Ozel S., Gul F., ILGIN C., TİGEN E., Altunal L. N., ...More

MARMARA MEDICAL JOURNAL, vol.34, no.2, pp.112-119, 2021 (ESCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 34 Issue: 2
  • Publication Date: 2021
  • Doi Number: 10.5472/marumj.942700
  • Journal Name: MARMARA MEDICAL JOURNAL
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, CINAHL, EMBASE, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.112-119
  • Marmara University Affiliated: Yes

Abstract

Objective: This study aimed to identify the effect of tocilizumab (TCZ) on clinical outcomes in severe COVID-19 patients.